What type of study is this?

This is a Human Clinical Trial study (also classified as: Pre-Registered Trial, RCT).

November 28, 2025NEJM Evidence1 citations

Minimally Invasive versus Open Pancreatoduodenectomy for Resectable Neoplasms

NGNine de Graaf AEAnouk M. L. H. Emmen MRMarco Ramera

Key Points

Noninferior overall complications observed following minimally invasive versus open pancreatoduodenectomy.
Patients experienced 90-day overall complications rates similar in both approaches, indicating effective surgical options.
Assessment using clinical data from patients with resectable pancreatic and periampullary neoplasm suggests favorable outcomes.
Findings may guide surgical decisions, although further studies are needed for broader applicability.

Abstract

In patients with resectable pancreatic and periampullary neoplasm, MIPD was noninferior to OPD for 90-day overall complications (Funded by Intuitive Surgical and Fondazione Poliambulanza Istituto Ospedaliero; International Standard Randomised Controlled Trial Number Registry, ISRCTN27483786.).

Ask AI

Helpful

Bookmark

View Full Paper